Table 5.

Univariable and multivariable regression analysis for predictors of continence 1 and 3 months

Predictors	1 Month				3 Months
	Univariable		Multivariable		Univariable		Multivariable
	OR, 95% CI	P value	OR, 95% CI	P value	OR, 95% CI	P value	OR, 95% CI	P value
Age	1.001, 0.980–1.021	0.959	1.001, 0.979–1.023	0.940	1.019, 0.998–1.041	0.080	1.018, 0.996–1.041	0.113
BMI	1.036, 0.981–1.094	0.209	1.023, 0.963–1.086	0.460	1.001, 0.948–1.057	0.964	0.998, 0.941–1.059	0.947
HP	1.398, 0.998–1.957	0.051	1.376, 0.947–1.999	0.094	1.365, 0.980–1.901	0.066	1.404, 0.978–2.015	0.066
DM	1.138, 0.734–1.764	0.563	0.999, 0.626–1.595	0.998	0.857, 0.550–1.334	0.493	0.748, 0.470–1.190	0.220
CHD	1.529, 0.878–2.665	0.134	1.476, 0.817–2.688	0.197	1.028, 0.605–1.750	0.917	0.885, 0.508–1.542	0.665
CD	0.831, 0.340–2.034	0.685	0.739, 0.289–1.889	0.528	1.582, 0.649–3.856	0.313	1.456, 0.582–3.640	0.422
PSA	1.004, 0.999–1.009	0.114	1.000, 0.995–1.005	0.985	1.003, 0.999–1.008	0.138	1.002, 0.997–1.006	0.501
PV	0.995, 0.987–1.003	0.212	0.994, 0.986–1.002	0.159	0.996, 0.988–1.004	0.348	0.995, 0.987–1.004	0.262
Gleason score	0.929, 0.774–1.116	0.433	0.801, 0.654–0.981	0.332	0.965, 0.802–1.160	0.702	0.926, 0.758–1.131	0.449
Clinical stage	1.060, 0.899–1.250	0.487	1.013, 0.850–1.208	0.883	1.077, 0.913–1.270	0.379	1.071, 0.902–1.273	0.434
OT	1.001, 0.998–1.004	0.551	1.000, 0.996–1.003	0.931	1.002, 0.999–1.006	0.193	1.002, 0.998–1.005	0.281
NS	0.372, 0.248–0.557	0.000	0.360, 0.231–0.561	0.000	0.549, 0.356–0.846	0.007	0.546, 0.342–0.872	0.011
PLND	1.517, 1.018–2.079	0.009	1.535, 1.079–2.184	0.017	1.051, 0.767–1.441	0.757	0.978, 0.690–1.386	0.901
DIC	0.998, 0.983–1.013	0.809	0.999, 0.983–1.014	0.869	0.996, 0.980–1.012	0.602	0.997, 0.981–1.013	0.713

Abbreviations: BMI Body mass index, CHD Coronary heart disease, CD Cerebrovascular diseases, DM Diabetes mellitus, DIC Duration of indwelling catheter, HP Hypertension, NS Nerve-sparing, OT Operation time, PSA Prostate-specific antigen, PV Prostate volume, PLND Pelvic lymph node dissection